Authors
1 Department of Nursing, School of Nursing and Midwifery
2 Isfahan Clinical Toxicology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
Background: The need for a correct follow‑up for medical advices of health givers is the
cornerstone for avoiding drug‑related complications in especial period of elderly people life.
There isn’t any data about drug therapy regimens adherence of elderly people of Isfahan. In
this study, we aimed to cover this deficit. Materials and Methods: In this cross‑sectional study
which was carried out in Isfahan (Iran) in 2013 senior citizens (aged 65 or more) who were
taking at least one medication and had no record of residency in nursing homes were included.
We used Morisky medication adherence scale (after validation and reliability assessment for
using this questionnaire in Persian language) to evaluate the level of adherence in the study
population. Results: A total of 200 elderly participants were fully studied (n = 200, 61% females),
and 52% of them had poor medication adherence. 77.5% of participants were suffered from at
least four medical illnesses, and 18.5% of them were taking more than eight medications per
day. We have not found any significant statistical relationship between vision or hearing loss
disorders and the medication adherence of the participants). There was a significant positive
relationship between the level of education and medication adherence (P = 0.001), (2 = 0.29).
Conclusion: Low Medication adherence is a common and important drug issue in the elderly
in Isfahan. This issue can lead to medical complications and huge cost if it is not addressed
appropriately.
Keywords
Prevalence and outcomes of use of potentially inappropriate
medicines in older people: Cohort study stratified by residence in
nursing home or in the community. BMJ Qual Saf 2011;20:275‑81.
2. Büla C. Medication usage in the elderly: Outrage and delight. Rev
Med Suisse 2011;7:2163‑4.
3. De Grey, A.D., The desperate need for a biomedically useful
definition of “aging”. Rejuvenation Res 2013;16:89‑90.
4. Diamond J. Population history: Human melting pots in Southeast
Asia. Nature 2014;512:262‑3.
5. Eckardt R, Steinhagen‑Thiessen E, Kämpfe S, Buchmann N.
Polypharmacy and drug prescription in the elderly. Strategies for
optimization. Z Gerontol Geriatr 2014;47:293‑301.
6. Golestannejad A. Isfahan Statstical Year Book. Vol. 1. Isfahan:
Isfahan Municipality; 2013. p. 41‑92.
7. Huber M, Blumberg A, Chatterjee S, Haenisch B, Schlosser‑Weber G,
Broich K. Drug safety: Challenge in an aging society. Nervenarzt
2014;85:1352‑62.
8. Imani‑Nasab MH, Seyedin H, Majdzadeh R, Yazdizadeh B, Salehi M.
Development of evidence‑based health policy documents
in developing countries: A case of Iran. Glob J Health Sci
2014;6:27‑36.
9. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy
in elderly patients with and without acute coronary syndromes.
JAMA 2002;288:462‑7.
10. Lo, R., Geriatric pharmacotherapy: Problems with adherence. Int J
Psychiatr Nurs Res 2001;7:806‑14.
11. Normand SL, Zou KH. Sample size considerations in observational
health care quality studies. Stat Med 2002;21:331‑45.
12. Morisky DE, Ang A, Krousel‑Wood M, Ward HJ. Predictive validity
of a medication adherence measure in an outpatient setting. J Clin
Hypertens (Greenwich) 2008;110:348‑54.
13. Mårdby AC, Akerlind I, Hedenrud T. General beliefs about medicines
among doctors and nurses in out‑patient care: A cross‑sectional
study. BMC Fam Pract 2009;10:35.
14. Miller CA. Nursing for Wellness in Older Adults, Latin Book. 5th ed.
Philadelphia: Publish by Wolters Kluwer Health/Lippincott Williams
& Wilkins; 2009. p. 305‑408.
15. Maher RL, Hanlon J, Hajjar ER. Clinical consequences of
polypharmacy in elderly. Expert Opin Drug Saf 2014;13:57‑65.
16. McLaughlin SJ. A Public Health Approach to the Challenges of an
Aging Society. Gerontologist 2014; 9(7):723‑34.
17. Merchant EK. Global population: History, geopolitics, and life on
earth. Glob Public Health 2015;10:129‑31.
18. Mannucci PM, Nobili A, REPOSI Investigators. Multimorbidity and
polypharmacy in the elderly: Lessons from REPOSI. Intern Emerg
Med 2014;9:723‑34.
19. Son KY, Park SM, Lee J, Kim CY. Difference in adherence to and
influencing factors of a healthy lifestyle between middle‑aged and
elderly people in Korea: A multilevel analysis. Geriatr Gerontol Int
2014; Geriatrics & Gerontology International, 2014: p. 1‑11. PMID:
25256663.
20. Shokri S. The Compliance of Dialysis Patients with their Treatment
Regimens [Thesis for PharmD degree], in Department of Clinical
Pharmacy and Pharmacy Practice. Iran: Isfahan University of Medical
Sciences; 2009. p. 94.
21. Shariatirad S, Maarefvand M. Sanctions against Iran and the
impact on drug use and addiction treatment. Int J Drug Policy
2013;24:636‑7.
22. Tsai KT, Chen JH, Wen CJ, Kuo HK, Lu IS, Chiu LS, et al. Medication
adherence among geriatric outpatients prescribed multiple
medications. Am J Geriatr Pharmacother 2012;10:61‑8.
)